This has the look of an over-bought over-hyped biotech spike, triggered by the release of animal research that seeks to find a scientific basis for the Phase IIa trial results previously published.
All good research of course, but the translation into the market at this particular moment seems well OTT.
I suspect American desperation for an AD cure is driving this - it's a tabloid illness under an intense media spotlight.
There will be shirts (and more) lost in this spike. Take care.
3 bagger, page-2
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
-0.001(16.7%) |
Mkt cap ! $26.22M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $130.5K | 26.11M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 106 | 98813145 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 13634538 | 6 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| ATH (ASX) Chart |